Neuronal protection by sirtuins in Alzheimer's disease
- PMID: 16219030
- DOI: 10.1111/j.1471-4159.2005.03492.x
Neuronal protection by sirtuins in Alzheimer's disease
Abstract
Silent information regulator 2, a member of NAD+-dependent histone deacetylase in yeast, and its homologs in mice and humans, participate in numerous important cell functions, including cell protection and cell cycle regulation. The sirtuin family members are highly conserved evolutionarily, and are predicted to have a role in cell survival. The science of sirtuins is an emerging field and is expected to contribute significantly to the role of sirtuins in healthy aging in humans. The role of sirtuins in neuronal protection has been studied in lower organisms, such as yeast, worms, flies and rodents. Both yeast Sir2 and mammalian sirtuin proteins are up-regulated under calorie-restricted and resveratrol treatments. Increased sirtuin expression protects cells from various insults. Caloric restriction and antioxidant treatments have shown useful effects in mouse models of aging and Alzheimer's disease (AD) and in limited human AD clinical trials. The role sirtuins may play in modifying and protecting neurons in patients with neurodegenerative diseases is still unknown. However, a recent report of Huntington's disease revealed that Sirtuin protects neurons in a Huntington's disease mouse model, suggesting that sirtuins may protect neurons in patients with neurodegenerative diseases, such as AD. In this review, we discuss the possible mechanisms of sirtuins involved in neuronal protection and the potential therapeutic value of sirtuins in healthy aging and AD.
Similar articles
-
Therapeutic potential of sirtuin-activating compounds in Alzheimer's disease.Drug News Perspect. 2007 May;20(4):233-9. doi: 10.1358/dnp.2007.20.4.1101162. Drug News Perspect. 2007. PMID: 17637936 Review.
-
Resveratrol--a boon for treating Alzheimer's disease?Brain Res Rev. 2006 Sep;52(2):316-26. doi: 10.1016/j.brainresrev.2006.04.004. Brain Res Rev. 2006. PMID: 16766037 Review.
-
SIRT1 and neuronal diseases.Mol Aspects Med. 2008 Jun;29(3):187-200. doi: 10.1016/j.mam.2007.02.001. Epub 2007 Feb 16. Mol Aspects Med. 2008. PMID: 17397914 Review.
-
Mammalian sirtuins--emerging roles in physiology, aging, and calorie restriction.Genes Dev. 2006 Nov 1;20(21):2913-21. doi: 10.1101/gad.1467506. Genes Dev. 2006. PMID: 17079682 Review.
-
Sirtuins as novel targets for Alzheimer's disease and other neurodegenerative disorders: experimental and genetic evidence.J Alzheimers Dis. 2010;19(1):11-26. doi: 10.3233/JAD-2010-1215. J Alzheimers Dis. 2010. PMID: 20061622 Review.
Cited by
-
Brain activation of SIRT1: role in neuropathology.Mol Neurobiol. 2013 Dec;48(3):681-9. doi: 10.1007/s12035-013-8459-x. Epub 2013 Apr 25. Mol Neurobiol. 2013. PMID: 23615921 Review.
-
Trévo abrogates Lead Acetate Neurotoxicity in Male Wistar Rats viz Antiamyloidogenesis, Antiglutaminergic, and Anticholinesterase Activities.Ann Neurosci. 2022 Apr;29(2-3):94-103. doi: 10.1177/09727531221077642. Epub 2022 Mar 4. Ann Neurosci. 2022. PMID: 36419514 Free PMC article.
-
Alzheimer's Disease: From Mitochondrial Perturbations to Mitochondrial Medicine.Brain Pathol. 2016 Sep;26(5):632-47. doi: 10.1111/bpa.12402. Brain Pathol. 2016. PMID: 27327899 Free PMC article. Review.
-
Neuroprotective herbs and foods from different traditional medicines and diets.Molecules. 2010 May 14;15(5):3517-55. doi: 10.3390/molecules15053517. Molecules. 2010. PMID: 20657497 Free PMC article. Review.
-
Nutrition and prevention of Alzheimer's dementia.Front Aging Neurosci. 2014 Oct 20;6:282. doi: 10.3389/fnagi.2014.00282. eCollection 2014. Front Aging Neurosci. 2014. PMID: 25368575 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical